(Drug Name) (Drug Form) (Drug Strength)
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

MIRCERA: Solution for injection (100mcg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA (muh THOK see pol ee ETH i leen GLYE col - e POE e tin BAY ta) helps your body make more red blood cells. It is used to treat anemia caused by kidney failure.

In-Depth Information

MIRCERA 100mcg/0.3mL Solution for Injection

NDC: 000040403
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Anemia

Storage Information
Store at or below 77 degrees F for no more than 30 days if refrigeration is not available
Refrigerate (between 36 and 46 degrees F)
Store in original package until time of use
Protect from light
Discard product if it contains particulate matter, is cloudy, or discolored
Do not freeze
MIRCERA 100mcg/0.3mL Solution for Injection

Reported Side Effects for MIRCERA 100mcg/0.3mL Solution for Injection

Back Pain Incidence:
>6.0%*
Severity: MILD
Onset: DELAYED
Low Platelet Count Incidence:
>7.0%*
Severity: MODERATE
Onset: DELAYED
Swelling Incidence:
>7.0%*
Severity: MODERATE
Onset: DELAYED
Low Blood Pressure Incidence:
>8.0%*
Severity: MODERATE
Onset: RAPID
Headache Incidence:
>9.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
>11.0%*
Severity: MILD
Onset: EARLY
High Blood Pressure Incidence:
>13.0%*
Severity: MODERATE
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with MIRCERA

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5